Masamune Sakamoto

Masamune Sakamoto

Auto-generated profile, based on publicly available information

Masamune Sakamoto

Department of Human Genetics Yokohama City University Graduate School of Medicine Yokohama Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2023 in Brain and Development
Verified
Journal Article
Closed access
TMTatsuo Mori
Tatsuo Mori
MSMasamune Sakamoto
Masamune Sakamoto
TTTakahiro Tayama
Takahiro Tayama
AGAya Goji
Aya Goji
YTYoshihiro Toda
Yoshihiro Toda
NMNaomichi Matsumoto
Naomichi Matsumoto

28 October 2022 in Genetics in Medicine
Verified
Journal Article
Closed access
MSMasamune Sakamoto
Masamune Sakamoto
KIKazuhiro Iwama
Kazuhiro Iwama
MSMasayuki Sasaki
Masayuki Sasaki
AIAkihiko Ishiyama
Akihiko Ishiyama
HKHirofumi Komaki
Hirofumi Komaki
NMNaomichi Matsumoto
Naomichi Matsumoto

18 April 2024 in Brain and Development
Verified
Journal Article
Closed access
SSSebastián Silva
Sebastián Silva
MRMónica Rosas
Mónica Rosas
BGBenjamín Guerra
Benjamín Guerra
MMMarión Muñoz
Marión Muñoz
AFAtsushi Fujita
Atsushi Fujita
NMNaomichi Matsumoto
Naomichi Matsumoto

2 May 2025 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
NNNaoto Nishimura
Naoto Nishimura
TMTakeshi Mizuguchi
Takeshi Mizuguchi
KHKeisuke Hamada
Keisuke Hamada
KYKotaro Yuge
Kotaro Yuge
MSMasamune Sakamoto
Masamune Sakamoto
NMNaomichi Matsumoto
Naomichi Matsumoto

7 October 2025 in NAR Genomics and Bioinformatics
Verified
Journal Article
Open access
YUYasuhiro Utsuno
Yasuhiro Utsuno
KHKohei Hamanaka
Kohei Hamanaka
MSMasamune Sakamoto
Masamune Sakamoto
NTNaomi Tsuchida
Naomi Tsuchida
YUYuri Uchiyama
Yuri Uchiyama
NMNaomichi Matsumoto
Naomichi Matsumoto
Splicing variants significantly contribute to Mendelian disorders, yet predicting their pathogenicity remains challenging. To address this issue, we developed a framework that simplifies the evaluation of pathogenic splicing single nucleotide variants (SNVs) while following ACMG/AMP guidelines and ClinGen recommendations established in 2023. Our system simplifies the 2023 ClinGen criteria by assigning a priority score (ranging from −10 to 14) to SNVs in open reading frame regions. Validation using pathogenic splicing SNVs from the Human Gene Mutation Database and common SNVs from gnomAD demonstrated superior discrimination compared to SpliceAI alone (area under the receiver operating characteristic 0.991 versus 0.983, P = 2.11 × 10⁻23). When applied to 1257 patients with unresolved diagnoses after exome sequencing, our framework identified pathogenic splicing variants in COL2A1, PDHA1, MECP2, and JAKMIP1 and suggested potential candidate disease-causing genes, UBN1 and NFE2L1. This method enhances the detection of splicing variants in exome sequencing.

5 August 2025 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
CPCaroline Brandão Piai
Caroline Brandão Piai
GSGabriela Yumi Goto Salti
Gabriela Yumi Goto Salti
MAMarcella Cardoso Allegro
Marcella Cardoso Allegro
PBPriscila Barbosa Betty
Priscila Barbosa Betty
FVFernanda de Souza Valente
Fernanda de Souza Valente
CKChong Ae Kim
Chong Ae Kim